239 related articles for article (PubMed ID: 22189522)
1. Antifungal therapy and outcomes in infants with invasive Candida infections.
Ascher SB; Smith PB; Watt K; Benjamin DK; Cohen-Wolkowiez M; Clark RH; Benjamin DK; Moran C
Pediatr Infect Dis J; 2012 May; 31(5):439-43. PubMed ID: 22189522
[TBL] [Abstract][Full Text] [Related]
2. Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis.
Autmizguine J; Tan S; Cohen-Wolkowiez M; Cotten CM; Wiederhold N; Goldberg RN; Adams-Chapman I; Stoll BJ; Smith PB; Benjamin DK;
Pediatr Infect Dis J; 2018 Sep; 37(9):923-929. PubMed ID: 29369937
[TBL] [Abstract][Full Text] [Related]
3. Time to initiation of antifungal therapy for neonatal candidiasis.
Le J; Tran TT; Bui I; Wang MK; Vo A; Adler-Shohet FC
Antimicrob Agents Chemother; 2013 Jun; 57(6):2550-5. PubMed ID: 23507285
[TBL] [Abstract][Full Text] [Related]
4. Candida infections in non-neutropenic children after the neonatal period.
Hacimustafaoglu M; Celebi S
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):923-40. PubMed ID: 21973304
[TBL] [Abstract][Full Text] [Related]
5. [Invasive candidiasis in neonatal intensive care units].
Brissaud O; Tandonnet O; Guichoux J
Arch Pediatr; 2011 May; 18 Suppl 1():S22-32. PubMed ID: 21596283
[TBL] [Abstract][Full Text] [Related]
6. Persistently positive cultures and outcome in invasive neonatal candidiasis.
Chapman RL; Faix RG
Pediatr Infect Dis J; 2000 Sep; 19(9):822-7. PubMed ID: 11001103
[TBL] [Abstract][Full Text] [Related]
7. A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis.
Benjamin DK; Kaufman DA; Hope WW; Smith PB; Arrieta A; Manzoni P; Kovanda LL; Lademacher C; Isaacson B; Jednachowski D; Wu C; Kaibara A; Walsh TJ
Pediatr Infect Dis J; 2018 Oct; 37(10):992-998. PubMed ID: 29596222
[TBL] [Abstract][Full Text] [Related]
8. Old and new: appropriate dosing for neonatal antifungal drugs in the nursery.
Ericson J; Manzoni P; Benjamin DK
Early Hum Dev; 2013 Jun; 89 Suppl 1(0 1):S25-7. PubMed ID: 23809344
[TBL] [Abstract][Full Text] [Related]
9. Invasive fungal infections in newborns and current management strategies.
Hundalani S; Pammi M
Expert Rev Anti Infect Ther; 2013 Jul; 11(7):709-21. PubMed ID: 23829639
[TBL] [Abstract][Full Text] [Related]
10. Systematic review on the first line treatment of amphotericin B in critically ill adults with candidemia or invasive candidiasis.
Keane S; Geoghegan P; Povoa P; Nseir S; Rodriguez A; Martin-Loeches I
Expert Rev Anti Infect Ther; 2018 Nov; 16(11):839-847. PubMed ID: 30257597
[TBL] [Abstract][Full Text] [Related]
11. Systemic antifungal drugs for invasive fungal infection in preterm infants.
Clerihew L; McGuire W
Cochrane Database Syst Rev; 2004; (1):CD003953. PubMed ID: 14974045
[TBL] [Abstract][Full Text] [Related]
12. Neonatal candidiasis: prophylaxis and treatment.
Tiffany KF; Smith PB; Benjamin DK
Expert Opin Pharmacother; 2005 Aug; 6(10):1647-55. PubMed ID: 16086651
[TBL] [Abstract][Full Text] [Related]
13. Fluconazole prophylaxis for prevention of invasive candidiasis in infants.
Ericson JE; Benjamin DK
Curr Opin Pediatr; 2014 Apr; 26(2):151-6. PubMed ID: 24626156
[TBL] [Abstract][Full Text] [Related]
14. Therapies against murine Candida guilliermondii infection, relationship between in vitro antifungal pharmacodynamics and outcome.
Paredes K; Pastor FJ; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Guarro J
Rev Iberoam Micol; 2015; 32(1):34-9. PubMed ID: 24594291
[TBL] [Abstract][Full Text] [Related]
15. Advances in the treatment of invasive neonatal candidiasis.
Botero-Calderon L; Benjamin DK; Cohen-Wolkowiez M
Expert Opin Pharmacother; 2015 May; 16(7):1035-48. PubMed ID: 25842986
[TBL] [Abstract][Full Text] [Related]
16. Amphotericin B deoxycholate for candidiasis in intensive care unit patients revisited: medical, ethical, and financial implications.
Dreyfuss D; Ricard JD; Gaudry S
Am J Respir Crit Care Med; 2013 Mar; 187(6):661-3. PubMed ID: 23504365
[No Abstract] [Full Text] [Related]
17. Adrenocortical insufficiency is not a problem in preterm infants treated with antifungal prophylaxis with fluconazole.
Costa S; Barone G; Vento G; Tirone C; Perelli S; Romagnoli C
Acta Paediatr; 2014 Jun; 103(6):e234-7. PubMed ID: 24575768
[TBL] [Abstract][Full Text] [Related]
18. Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial.
Benjamin DK; Hudak ML; Duara S; Randolph DA; Bidegain M; Mundakel GT; Natarajan G; Burchfield DJ; White RD; Shattuck KE; Neu N; Bendel CM; Kim MR; Finer NN; Stewart DL; Arrieta AC; Wade KC; Kaufman DA; Manzoni P; Prather KO; Testoni D; Berezny KY; Smith PB;
JAMA; 2014 May; 311(17):1742-9. PubMed ID: 24794367
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind trial investigating the efficacy of caspofungin versus amphotericin B deoxycholate in the treatment of invasive candidiasis in neonates and infants younger than 3 months of age.
Kim J; Nakwa FL; Araujo Motta F; Liu H; Dorr MB; Anderson LJ; Kartsonis N
J Antimicrob Chemother; 2020 Jan; 75(1):215-220. PubMed ID: 31586424
[TBL] [Abstract][Full Text] [Related]
20. Eradication of severe neonatal systemic candidiasis with amphotericin B lipid complex.
Knoppert DC; Salama HE; Lee DS
Ann Pharmacother; 2001 Sep; 35(9):1032-6. PubMed ID: 11573851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
